PDL BioPharma, Inc. Free Cash Flow

Free Cash Flow of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow growth rates and interactive chart. Free cash flowis calculated as operating cash flow minus of capital expenditures. Interest payments are excluded from the generally accepted definition of free cash flow. Free cash flow is the cash flow available to all the investors in a company, including common stockholders, preferred shareholders, and lenders. Some investors prefer FCF or FCF per share over earnings and earnings per share as a measure of profitability. However, because FCF accounts for investments in property, plant, and equipment it can be lumpy over time. Free cash flow is usually used in discounted cash flow models to determine a company's intrinsic value.


Highlights and Quick Summary

  • Free Cash Flow for the quarter ending June 29, 2020 was $-20.3 Million (a 32.58% increase compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow decreased by -170.24%
  • Annual Free Cash Flow for 2019 was $49.4 Million (a 23.35% increase from previous year)
  • Annual Free Cash Flow for 2018 was $40 Million (a -72.7% decrease from previous year)
  • Annual Free Cash Flow for 2017 was $147 Million (a 27.71% increase from previous year)
  • Twelve month Free Cash Flow ending June 29, 2020 was $-6.85 Million (a -85.18% decrease compared to previous quarter)
  • Twelve month trailing Free Cash Flow decreased by -110.4% year-over-year
Trailing Free Cash Flow for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-6.85 Million $-46.2 Million $70.3 Million $65.8 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow of PDL BioPharma, Inc.

Most recent Free Cash Flowof PDLI including historical data for past 10 years.

Interactive Chart of Free Cash Flow of PDL BioPharma, Inc.

PDL BioPharma, Inc. Free Cash Flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-20.35 $-15.35
2019 $1.58 $28.97 $21.16 $-2.35 $49.37
2018 $18.97 $6.73 $29.24 $-14.92 $40.02
2017 $15.27 $22.34 $42.34 $66.63 $146.58
2016 $40.97 $-52.86 $16.93 $109.73 $114.78
2015 $104.52 $-32.64 $85.21 $72.78 $229.86
2014 $24.19 $109.34 $88.29 $91.78 $313.59
2013 $-180.1 $45.83 $109.85 $52.86 $28.43
2012 $53.85 $35.83 $104.89 $17.89 $212.46
2011 $45.15 $36.71 $101.03 $-13.15 $169.78
2010 $29.99 $30.69 $96.69 $184.3

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.